About Niall O'Donnell
Form D filings for Avalyn Pharma from 2017 to 2023 list Niall O'Donnell as director.
Niall O'Donnell reports to the SEC as a director of 3 public companies: OnKure Therapeutics (OKUR), Spruce Biosciences (SPRB) and Mirum Pharmaceuticals (MIRM).
Niall O'Donnell first appears on SEC filings in 2017.
Experience
This experience comes from SEC filings. The years are when the filings name Niall O'Donnell in the role, so the role may have started earlier or lasted longer.
OI
OnKure Therapeutics, Inc.
Director
2021 – 2023 · Public company (OKUR)
SI
Spruce Biosciences, Inc.
Director
2020 – 2023 · Public company (SPRB)
MI
Mirum Pharmaceuticals, Inc.
Director
2019 – 2022 · Public company (MIRM)
Key Colleagues at Startups
The people Niall O'Donnell works with at each company, as listed on that company's latest Form D.
Avalyn Pharma Inc. · Form D, Oct 10, 2023
LB
Lyn Baranowski
Chief Executive Officer and director
TA
Tiba Aynechi
Director
KP
Ketan Patel
Director
PM
Peter Moldt
Director
CL
Cassandra Luca
Director
JL
Jonathan Leff
Director
JC
Jill Carroll
Director